Source: https://tendernation.io/opportunities/01a13be7-5870-72ff-9da6-0c0bb6995e15/unlocking-space-for-business-in-orbit-rd-and-manufacturing-of-pharmaceuticals pending GB open procedure Suitable for SMEs # Unlocking Space for Business: In-orbit R&D and manufacturing of pharmaceuticals RFI [Department for Science, Innovation & Technology](https://tendernation.io/buyers/department-for-science-innovation-technology) Incumbent usually keeps it Estimated value Not stated Published 13 Aug 2026 Deadline Rolling deadline ## Who can bid - Buyer says suitable for SMEs The buyer ticked “suitable for SMEs” on the notice. Anyone can still bid. - Buyer says suitable for VCSEs The buyer ticked “suitable for voluntary, community and social enterprises” on the notice. - Below-threshold contract Buyers cannot shortlist bidders on suitability before tenders are in, so everyone gets to submit a bid (except some larger works contracts). [Procurement Act 2023, section 85](https://www.legislation.gov.uk/ukpga/2023/54/section/85) - Open procedure Anyone can submit a full tender; there is no shortlisting stage. [More contracts for small businesses and VCSEs](https://tendernation.io/opportunities/for-small-businesses) ## About this tender The UK Space Agency is working across government, regulators, industry and healthcare to help create the conditions needed for the in-orbit pharmaceuticals manufacturing and drug discovery market to develop. USB has played a convening role in bringing together the Medicines and Healthcare products Regulatory Agency (MHRA), the Civil Aviation Authority (CAA) and the Regulatory Innovation Office (RIO) within the Department for Business, Innovation, Science and Trade (BIST) to publish a joint statement on regulatory clarity for in-orbit manufacturing of pharmaceuticals. We are also working with MHRA to develop a regulatory roadmap for space-enabled pharmaceutical manufacturing, to provide greater clarity and confidence for industry. Following sustained evidence-gathering from the Unlocking Space Portfolio, including participation in the recent UK-Swiss Microgravity Biopharma Dialogue, clear pain-points and barriers to the adoption of in-orbit manufacturing of pharmaceuticals have emerged, which are currently experienced by UK stakeholders including prospective end-users, space biotech companies and investors. This Request for Information (RFI) builds directly on this Dialogue, and the questions below are designed to test, validate and extend that evidence base with wider stakeholder input. The UK Space Agency requests your input to ensure that any future support or commercialisation opportunities for in-orbit manufacturing of pharmaceuticals or in-orbit R&D directly address these identified barriers and are prioritised based on the needs of stakeholders in this domain. This RFI will help guide the UK Space Agency’s interventions for space biopharma companies, prospective pharmaceutical end-users and space/biotech investors. This RFI is not directly connected to an existing funding route, but it may help to shape and inform future non-financial support interventions and commercial activities. We welcome your responses and are grateful in advance for the time and effort taken in replying to this Request for Information. ### Our aims – what we want to achieve The goals of this Request for Information are: To understand what existing and new barriers industry, end-users, academia and investors are facing on the commercialisation of IOM pharmaceuticals or in-orbit pharmaceuticals R&D, and the impact of these barriers; To understand what interventions have been effective at addressing these identified barriers and what new interventions would further support IOM pharmaceuticals or in-orbit pharmaceuticals R&D; and To understand where government is best placed to address these barriers and what international comparators we could learn from to inform potential future government interventions. This RFI is not related to any ongoing or future funding calls from the UK Space Agency, but it may help to shape and inform future non-financial support interventions and commercial activities. The UK Space Agency does not commit to cover any cost incurred in the preparation or submission of any response to the RFI. Responding or failing to respond to this RFI will not preclude the respondents from participating in any future UK Space Agency calls or requests for information or other funding opportunities. In recognition of stakeholder availability over the summer period, the deadline for responses is 17:00 BST, 7 September 2026. If more time is needed to provide a response or if there are additional questions about the process, please contact with “Unlocking Space for Business IOM Pharma RFI” as the subject line. An email confirmation of receipt from the UK Space Agency will be sent within a one-week period to the designated point of contact. The UK Space Agency reserves the right to follow-up and ask clarification questions on any responses. Read full description ## CPV classification Medical equipments, pharmaceuticals and personal care products Satellite platforms Spacecraft, satellites and launch vehicles Research services Source Find a Tender (UK) · Notice ocds-h6vhtk-06e33a-2026-08-13T09:51:14+01:00 [View official notice](https://www.find-tender.service.gov.uk/Notice/ocds-h6vhtk-06e33a-2026-08-13T09:51:14+01:00) Never miss a tender like this again Get AI summaries, deadline alerts and a bid pipeline for tenders matched to your business. Free to start. [Track tenders free](https://tendernation.io/register) [Buyer profile Department for Science, Innovation & Technology: past awards and live tenders](https://tendernation.io/buyers/department-for-science-innovation-technology) [Sector More Medical equipment & pharmaceuticals tenders](https://tendernation.io/sectors/medical-equipment-pharmaceuticals) ## More tenders like this [Autoclaves – Autoklaver till Tandvårdshögskolan i Malmö · Malmö universitet · 9 days left · 28 Oct 2026](https://tendernation.io/opportunities/01a156a9-9dd7-7329-993d-a6e0f71667e9/sweden-autoclaves-autoklaver-till-tandvardshogskolan-i-malmo) [Pharmaceutical products – Open-House-Rabattverträge 2026-17 Tafamidis · Techniker Krankenkasse · 773 days left · 30 Nov 2028](https://tendernation.io/opportunities/01a156a9-aa23-7217-b0b6-daa9dc9fe3b2/germany-pharmaceutical-products-open-house-rabattvertrage-2026-17-tafamidis) [Enteral feeds – Enteralna prehrana · Klinički Bolnički Centar Split · 32 days left · 20 Nov 2026](https://tendernation.io/opportunities/01a156a9-61f0-727d-a7e5-8af11fde40a5/croatia-enteral-feeds-enteralna-prehrana) [Operating-theatre devices – Operační stoly · Fakultní nemocnice Brno · 31 days left · 19 Nov 2026](https://tendernation.io/opportunities/01a156a9-6f95-7385-a1b5-a45251fdf818/czechia-operating-theatre-devices-operacni-stoly) [Orthopaedic implants – Dostawa implantów ortopedycznych · Uniwersytecki Szpital Kliniczny w Białymstoku · 31 days left · 19 Nov 2026](https://tendernation.io/opportunities/01a156a9-a014-7092-93fd-a23b17232c85/poland-orthopaedic-implants-dostawa-implantow-ortopedycznych) [Laboratory reagents – Dostawa odczynników oraz dzierżawa analizatorów. · Szpital Specjalistyczny w Chorzowie · 8 days left · 27 Oct 2026](https://tendernation.io/opportunities/01a156a9-ca42-73b8-a366-fed6ba8a391f/poland-laboratory-reagents-dostawa-odczynnikow-oraz-dzierzawa-analizatorow)